CORZ
Core Scientific·NASDAQ
--
--(--)
--
--(--)
CORZ fundamentals
Core Scientific (CORZ) released its earnings on Aug 8, 2025: revenue was 78.63M (YoY -44.27%), missed estimates; EPS was -0.04 (YoY +20.00%), missed estimates.
Revenue / YoY
78.63M
-44.27%
EPS / YoY
-0.04
+20.00%
Report date
Aug 8, 2025
EPS
Revenue
Revenue & Expenses
CORZ has released its 2025 Q3 earnings report, with revenue of 81.10M, reflecting a YoY change of -14.95%, and net profit of -146.66M, showing a YoY change of 67.79%. The Sankey diagram below clearly presents CORZ's revenue sources and cost distribution.
Key Indicators
Core Scientific (CORZ) key financial stats and ratios, covering profitability, financial health, and leverage.
Core Scientific (CORZ)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Core Scientific (CORZ)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Core Scientific (CORZ)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Core Scientific (CORZ) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Core Scientific (CORZ) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Core Scientific year over year?What is Core Scientific's gross profit margin?Did Core Scientific beat or miss consensus estimates last quarter?What were the key takeaways from Core Scientific's earnings call?What is the market's earnings forecast for Core Scientific next quarter?What factors drove the changes in Core Scientific's revenue and profit?What guidance did Core Scientific's management provide for the next earnings period?What were the key takeaways from Core Scientific’s earnings call?
